George Rodrigues1,2, Glenn Bauman1, Varagur Venkatesan1, Belal Ahmad1, Michael Lock1, Tracy Sexton1, David D’Souza1, Larry Stitt2, Somaya Eid1,2
Canadian Journal of Urology, Vol.18, No.4, pp. 5802-5810, 2011
Abstract Introduction: A 29-item prostate cancer radiotherapy (PCRT) questionnaire with genitourinary (GU), gastrointestinal (GI), and sexual (S) domains has been previously validated for the assessment of late toxicity health-related quality of life (HRQoL) effects. The study objective was to cross-validate the PCRT domains versus the expanded prostate cancer index composite (EPIC) questionnaire urinary (U), bowel (B), hormonal (H), and S subscales.
Methods and materials: A single-institution cross-sectional PCRT patient cohort was surveyed. Descriptive and intra- and inter-class correlation coefficient statistics for the various EPIC and PCRT HRQoL domain scores were generated. Univariable and multivariable Cox and logistic regressions… More >